US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Retension Pharmaceuticals Inc

10.53

-1.4700-12.25%

Post-market: 10.04-0.4906-4.66%19:46 EDT

Volume:789.20K

Turnover:8.12M

Market Cap:82.99M

PE:-6.95

High:11.60

Open:10.00

Low:9.66

Close:12.00

52wk High:11.60

52wk Low:9.66

Shares:7.88M

Float Shares:3.30M

Volume Ratio:- -

T/O Rate:23.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5150

ROE:--

ROA:--

PB:-5.56

PE(LYR):- -

Loading ...

Overview Company News Filings

Retension Pharmaceuticals Shares Fall After Nasdaq Debut

MT Newswires Live

Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening

Retension Pharmaceuticals Shares Slide in Trading Debut After IPO

City Therapeutics Eyes Valuation of up to $956.3 Million in US IPO Amid Biotech Listing Push

NASDAQ Trade Halt Reason not Available at 04:00 Am

Retension Pharmaceuticals Prices $45 Million IPO

MT Newswires Live

Retension Pharmaceuticals Announces Pricing of Initial Public Offering

THOMSON REUTERS

Retension Pharmaceuticals - Prices Upsized IPO of 3.75 Mln Shares at $12 Per Share

THOMSON REUTERS

Retension Pharmaceuticals Sets IPO Price Range at $11-$13 per Share to Raise $40 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/RTSN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RTSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","market":"US","secType":"STK","nameCN":"Retension Pharmaceuticals Inc","latestPrice":10.53,"timestamp":1791576000000,"preClose":12,"halted":0,"volume":789201,"hourTrading":{"tag":"盘后","latestPrice":10.0394,"preClose":10.53,"latestTime":"19:46 EDT","volume":12794,"amount":139374.6794,"timestamp":1791589602852,"change":-0.4906,"changeRate":-0.046591,"amplitude":0.092175},"delay":0,"changeRate":-0.12250000000000005,"floatShares":3300000,"shares":7881600,"eps":-1.515,"marketStatus":"Closed","change":-1.47,"latestTime":"10-09 16:00:00 EDT","open":10,"high":11.6,"low":9.66,"amount":8121801.655169999,"amplitude":0.161667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.515,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":5,"adr":0,"listingDate":1791518400000,"exchange":"NASDAQ","adjPreClose":12,"postHourTrading":{"tag":"盘后","latestPrice":10.0394,"preClose":10.53,"latestTime":"19:46 EDT","volume":12794,"amount":139374.6794,"timestamp":1791589602852,"change":-0.4906,"changeRate":-0.046591,"amplitude":0.092175},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","floatShares":3300000,"roa":"--","roe":"--","lyrEps":0,"shares":7881600,"dividePrice":0,"high":11.6,"amplitude":0.161667,"preClose":12,"low":9.66,"week52Low":9.66,"pbRate":"-5.56","week52High":11.6,"institutionHeld":0,"latestPrice":10.53,"eps":-1.515,"divideRate":0,"volume":789201,"delay":0,"ttmEps":-1.515,"open":10,"prevYearClose":12,"prevWeekClose":12,"prevMonthClose":12,"prevQuarterClose":12,"fiveDayClose":12,"twentyDayClose":12,"sixtyDayClose":12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RTSN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RTSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RTSN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RTSN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674962865","title":"Retension Pharmaceuticals Shares Fall After Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2674962865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674962865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:37","pubTimestamp":1791563843,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals  shares were down more than 11% in Friday trading after the company began trading on Nasdaq.The shares were trading at $10.64 after opening at $10 and reaching a high of $11.60.The company priced its initial public offering at $12 per share, expecting to raise $45 million in gross proceeds. The offering is expected to close Tuesday, Retension said late Thursday.Price: 10.64, Change: -1.37, Percent Change: -11.38","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LCLG","RTSN","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144830990","title":"Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1144830990","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144830990?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:28","pubTimestamp":1791563294,"startTime":"0","endTime":"0","summary":"According to reports, on Friday, Retension Pharmaceuticals Inc (RTSN.US) listed on the US stock market. As of press time, the stock had fallen more than 10% to $10.77. The IPO price was $12.Retension...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RTSN","MRNY","BK1610","03069","BBP","MRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674650865","title":"Retension Pharmaceuticals Shares Slide in Trading Debut After IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2674650865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674650865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:24","pubTimestamp":1791563040,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals shares fell sharply in their trading debut after the clinical-stage biopharmaceutical company's upsized initial public offering was priced at the midpoint of expectations.Sha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REDS","FRHC","KCE","IPOS","BK4127","RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856131","title":"City Therapeutics Eyes Valuation of up to $956.3 Million in US IPO Amid Biotech Listing Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856131","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674856131?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:13","pubTimestamp":1791544412,"startTime":"0","endTime":"0","summary":"City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing pushOct 9 (Reuters)-City Therapeutics on Friday said it is targeting a valuation of up to $956.3 million in its ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674305834","title":"NASDAQ Trade Halt Reason not Available at 04:00 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2674305834","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674305834?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:00","pubTimestamp":1791532802,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTREASON NOT AVAILABLE AT 04:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nAQN2MNI3I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674683107","title":"Retension Pharmaceuticals Prices $45 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2674683107","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674683107?lang=en_us&edition=fundamental","pubTime":"2026-10-09 15:58","pubTimestamp":1791532684,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals  priced its initial public offering of 3.8 million shares at $12.00 each, the company said late Thursday.Gross proceeds are expected to be $45.0 million, the company said.The company is expected to begin Nasdaq trading Friday under the ticker symbol \"RTSN\" and the offering is expected to close Tuesday.The company has also granted underwriters a 30-day option to purchase up to 562,500 additional shares, it said.Retension plans to use net proceeds from the offering, along with existing cash and cash equivalents, to complete its phase 2b clinical trial of RTN-001 in uncontrolled hypertension and prepare for a planned phase 3 trial as well as for general corporate purposes, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4127","REDS","KCE","RTSN","FRHC","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884380","title":"Retension Pharmaceuticals Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884380","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674884380?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:35","pubTimestamp":1791509746,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nTUA4RKPWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674313884","title":"Retension Pharmaceuticals - Prices Upsized IPO of 3.75 Mln Shares at $12 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2674313884","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674313884?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:35","pubTimestamp":1791509746,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nTUA4RKPWR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125056325","title":"Retension Pharmaceuticals Sets IPO Price Range at $11-$13 per Share to Raise $40 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1125056325","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125056325?lang=en_us&edition=fundamental","pubTime":"2026-10-06 17:08","pubTimestamp":1791277694,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals (RTSN.US), a developer of hypertension drugs, announced the terms of its initial public offering on Monday.The company plans to offer 3.3 million shares at a price range of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDN","IPOS","UUP","RTSN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}